Centre Of Research Excellence In Medicines Intelligence
Funder
National Health and Medical Research Council
Funding Amount
$2,500,000.00
Summary
The NHMRC Centre of Research Excellence in Medicines Intelligence is a co-ordinated research program that will accelerate the development and translation of evidence on prescribed medicines use and outcomes for regulators and payers. The CRE is perfectly placed to embrace the national ‘call to action’ from the Health Minister's recent announcement to establish Quality Use of Medicine Safety as a National Health Priority.
Web Services Reputation Management. This project directly supports the National Research Priority 4: Safeguarding Australia. More specifically, it aims at creating mechanisms that will make it more difficult to use the Internet as a platform for launching attacks against the business processes of Australian organisations that provide and consume Web services. At the same time this will stimulate the establishment of high quality WS markets. As direct social benefit of this research, Australian o ....Web Services Reputation Management. This project directly supports the National Research Priority 4: Safeguarding Australia. More specifically, it aims at creating mechanisms that will make it more difficult to use the Internet as a platform for launching attacks against the business processes of Australian organisations that provide and consume Web services. At the same time this will stimulate the establishment of high quality WS markets. As direct social benefit of this research, Australian organisations will be able to integrate the best quality Web services as part of their business processes, and thereby avoid being negatively impacted by low quality and deceptive Web services. Read moreRead less
An investigation of the impacts of increased power supply to the national grid by wind generators on the Australian electricity industry. The aim of this project is to discover the most economical and effective way to accommodate large increases in wind power into the national grid and to understand the effects on the national electricity market. This is crucial to ensure stability of electricity supply and affordable prices in the transition towards a low carbon economy.
Pharmacology Of Potential Anti-Tumour Agents: Iron Chelators Of The BpT Class
Funder
National Health and Medical Research Council
Funding Amount
$585,455.00
Summary
Pharmacology of Potential Anti-Tumour Agents: Iron Chelators of the BpT Class Cancer cells have a high iron requirement for DNA synthesis and many clinical trials showed Fe chelators are effective anti-cancer drugs. Their potential to act as anti-tumour agents has been confirmed by the entrance of Triapine into widespread NCI clinical trials. In this NHMRC Renewal, we will perform pharmacological and preclinical studies to promote the development of BpT chelators as novel anti-tumour agents.
Re-EValuating The Inhibition Of Stress Erosions (REVISE): Gastrointestinal Bleeding Prophylaxis In ICU
Funder
National Health and Medical Research Council
Funding Amount
$2,955,164.00
Summary
Around 50,000 patients in Australian Intensive Care Units receive a drug called pantoprazole each year with the aim of preventing bleeding from the gut. Recent research suggests this practice is ineffective and may harm patients by increasing their risk of serious infections. We will perform a definitive study to determine whether the widespread use of pantoprazole is beneficial or harmful.